Elizabeth R Goy1, Linda Ganzini. 1. Mental Health Division and Health Services Research and Development Program, Portland Veterans Affairs Medical Center, Portland, Oregon 97207, USA.
Abstract
CONTEXT: Prospective studies are needed to adequately describe the overall impact of neuropsychiatric syndromes on the course of hospice enrollment in outpatient settings. OBJECTIVES: To determine the prevalence and natural history of delirium, cognitive impairment, alcohol abuse, anxiety, depression, and suicidal ideation (SI) in community-dwelling veteran hospice patients. METHODS: Home hospice patients were visited regularly from enrollment until their deaths, study withdrawal, or discharge from hospice. Family caregivers gave consent for those with Mini-Mental State Examination (MMSE) scores less than or equal to 23. Measures included the Structured Clinical Interview for DSM-IV for depression (past and current) and alcohol abuse; the Hospital Anxiety and Depression Scale; MMSE; and Confusion Assessment Method (CAM). A clinician-rated CAM item documented sleep disturbance, and participants were asked about SI at each visit. RESULTS: The median length of hospice enrollment was 81 days. Of 88 participants, 77 (88%) experienced at least one neuropsychiatric syndrome. Cognitive impairment was prevalent, with 60 (68%) registering MMSE less than or equal to 23 at least once. More than half of the participants developed delirium; the proportion with delirium, any cognitive impairment, sleep disturbance, or any neuropsychiatric syndrome increased significantly from first to last study visit. Twelve (14%) participants had SI during the study, and 30 (34%) participants were affected by depression overall. Sixteen patients who were not depressed on admission subsequently developed depression. Anxiety was present in 14 (16%) on at least one study visit. Active alcohol abuse remained relatively stable (8%) across visits. CONCLUSIONS: Psychiatric syndromes are highly prevalent in hospice patients. Systematic case finding of psychiatric disorders may be necessary to improve quality of life in the last months of life.
CONTEXT: Prospective studies are needed to adequately describe the overall impact of neuropsychiatric syndromes on the course of hospice enrollment in outpatient settings. OBJECTIVES: To determine the prevalence and natural history of delirium, cognitive impairment, alcohol abuse, anxiety, depression, and suicidal ideation (SI) in community-dwelling veteran hospice patients. METHODS: Home hospice patients were visited regularly from enrollment until their deaths, study withdrawal, or discharge from hospice. Family caregivers gave consent for those with Mini-Mental State Examination (MMSE) scores less than or equal to 23. Measures included the Structured Clinical Interview for DSM-IV for depression (past and current) and alcohol abuse; the Hospital Anxiety and Depression Scale; MMSE; and Confusion Assessment Method (CAM). A clinician-rated CAM item documented sleep disturbance, and participants were asked about SI at each visit. RESULTS: The median length of hospice enrollment was 81 days. Of 88 participants, 77 (88%) experienced at least one neuropsychiatric syndrome. Cognitive impairment was prevalent, with 60 (68%) registering MMSE less than or equal to 23 at least once. More than half of the participants developed delirium; the proportion with delirium, any cognitive impairment, sleep disturbance, or any neuropsychiatric syndrome increased significantly from first to last study visit. Twelve (14%) participants had SI during the study, and 30 (34%) participants were affected by depression overall. Sixteen patients who were not depressed on admission subsequently developed depression. Anxiety was present in 14 (16%) on at least one study visit. Active alcohol abuse remained relatively stable (8%) across visits. CONCLUSIONS: Psychiatric syndromes are highly prevalent in hospice patients. Systematic case finding of psychiatric disorders may be necessary to improve quality of life in the last months of life.
Authors: Christopher G Slatore; Elizabeth R Goy; Daniel J Oʼhearn; Eilis A Boudreau; Jean P OʼMalley; Dawn Peters; Linda Ganzini Journal: Am J Geriatr Psychiatry Date: 2012-04 Impact factor: 4.105
Authors: Donald R Sullivan; Solange Mongoue-Tchokote; Motomi Mori; Elizabeth Goy; Linda Ganzini Journal: Psychooncology Date: 2016-08-12 Impact factor: 3.894
Authors: Christine L Watt; Franco Momoli; Mohammed T Ansari; Lindsey Sikora; Shirley H Bush; Annmarie Hosie; Monisha Kabir; Erin Rosenberg; Salmaan Kanji; Peter G Lawlor Journal: Palliat Med Date: 2019-06-11 Impact factor: 4.762
Authors: Emily M Ellsworth; Kevin J Bacigalupo; Kavita R Palla; Seema S Limaye; Margaret J Walkosz; Sandra T Szczecinski; Katie J Suda Journal: Fed Pract Date: 2021-05